
Processa Pharmaceuticals PCSA
€ 1.70
4.08%
Land |
|
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
1.31 M |
Marktkapitalisierung |
$ 2.57 M |
EBITDA (LTM) |
$ -14 M |
P/E (LTM) |
-0.198842 |
P/S (LTM) |
- |
EPS (LTM) |
-10.36 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
AbbVie
ABBV
|
$ 263.04 | 0.49 % | $ 465 B | NYSE,SPB | ||
|
AbCellera Biologics
ABCL
|
$ 11.41 | 2.15 % | $ 3.41 B | Nasdaq Global Select Market | ||
|
Фармсинтез
LIFE
|
- | - | - | MOEX | ||
|
Aclaris Therapeutics
ACRS
|
$ 5.53 | 6.02 % | $ 678 M | Nasdaq Global Select Market | ||
|
ADC Therapeutics SA
ADCT
|
$ 1.09 | 3.74 % | $ 139 M | NYSE | ||
|
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market | ||
|
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | ||
|
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | ||
|
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | ||
|
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | ||
|
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | ||
|
Concert Pharmaceuticals
CNCE
|
- | - | $ 401 M | Nasdaq Global Market | ||
|
ADMA Biologics
ADMA
|
$ 8.61 | 0.16 % | $ 2.05 B | Nasdaq Global Market | ||
|
Eiger BioPharmaceuticals
EIGR
|
- | -9.21 % | $ 2.55 M | Nasdaq Global Market | ||
|
89bio
ETNB
|
- | - | $ 1.55 B | Nasdaq Global Market | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
- | - | $ 384 M | Nasdaq Global Select Market | ||
|
Fusion Pharmaceuticals
FUSN
|
- | - | $ 1.41 B | Nasdaq Global Select Market | ||
|
Guardion Health Sciences
GHSI
|
- | -0.31 % | $ 3.64 M | Nasdaq Capital Market | ||
|
Genocea Biosciences
GNCA
|
- | -15.0 % | $ 3.04 M | Nasdaq Global Select Market | ||
|
Gritstone Oncology
GRTS
|
- | 0.42 % | $ 213 M | Nasdaq Global Select Market | ||
|
G1 Therapeutics
GTHX
|
- | - | $ 370 M | Nasdaq Global Select Market,SPB | ||
|
Harpoon Therapeutics
HARP
|
- | - | $ 763 M | Nasdaq Global Select Market | ||
|
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | ||
|
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | ||
|
Intercept Pharmaceuticals
ICPT
|
- | - | $ 643 M | Nasdaq Global Select Market,SPB | ||
|
IGM Biosciences
IGMS
|
- | - | $ 76.9 M | Nasdaq Global Select Market,SPB | ||
|
IMV
IMV
|
- | - | $ 13.1 M | Nasdaq Global Select Market | ||
|
Intra-Cellular Therapies
ITCI
|
- | - | $ 13.6 B | Nasdaq Global Select Market,SPB | ||
|
Kinnate Biopharma
KNTE
|
- | - | $ 123 M | Nasdaq Global Select Market | ||
|
Chinook Therapeutics
KDNY
|
- | - | $ 2.6 B | Nasdaq Global Select Market | ||
|
Kaleido Biosciences
KLDO
|
- | -3.69 % | $ 12.4 M | Nasdaq Global Select Market | ||
|
Kronos Bio
KRON
|
- | 1.49 % | $ 50.8 M | Nasdaq Global Select Market | ||
|
Karuna Therapeutics
KRTX
|
- | - | $ 12.2 B | Nasdaq Global Market,SPB | ||
|
Landos Biopharma
LABP
|
- | 0.58 % | $ 144 M | Nasdaq Global Market | ||
|
La Jolla Pharmaceutical Company
LJPC
|
- | - | $ 154 M | Nasdaq Capital Market | ||
|
LogicBio Therapeutics
LOGC
|
- | - | $ 229 M | Nasdaq Global Market | ||
|
Lumos Pharma
LUMO
|
- | - | $ 35.3 M | Nasdaq Global Select Market | ||
|
Merrimack Pharmaceuticals
MACK
|
- | - | $ 216 M | Nasdaq Global Market | ||
|
Stealth BioTherapeutics Corp
MITO
|
- | - | $ 23.9 M | Nasdaq Global Select Market | ||
|
Mirati Therapeutics
MRTX
|
- | - | $ 3.3 B | Nasdaq Global Select Market,SPB | ||
|
NexImmune
NEXI
|
- | 70.13 % | $ 4.12 M | Nasdaq Global Market | ||
|
9 Meters Biopharma
NMTR
|
- | -42.97 % | $ 1.05 M | Nasdaq Global Select Market | ||
|
InVivo Therapeutics Holdings Corp.
NVIV
|
- | -37.48 % | $ 476 K | Nasdaq Capital Market | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
- | -19.68 % | $ 18.4 M | Nasdaq Capital Market | ||
|
ObsEva SA
OBSV
|
- | -15.52 % | $ 10.5 M | Nasdaq Global Select Market | ||
|
Oncorus
ONCR
|
- | -8.54 % | $ 3.19 M | Nasdaq Global Market | ||
|
OncoSec Medical Incorporated
ONCS
|
- | 31.87 % | $ 1.61 M | Nasdaq Global Select Market | ||
|
Oncternal Therapeutics
ONCT
|
- | -24.12 % | $ 1.56 M | Nasdaq Capital Market | ||
|
Opiant Pharmaceuticals
OPNT
|
- | - | $ 109 M | Nasdaq Global Select Market | ||
|
Orchard Therapeutics plc
ORTX
|
- | 1.02 % | $ 90.8 M | Nasdaq Global Select Market |